ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2020 American Transplant Congress

    Belatacept Provides Superior Inhibition of Donor Specific Antibody Formation in Kidney Transplant Recipients with Acute Rejection

    O. Cristea, C. Larsen, I. Badell

    Emory Transplant Center, Emory University School of Medicine, Atlanta, GA

    *Purpose: The factors responsible for chronic renal allograft dysfunction and premature graft loss are incompletely understood and likely multifactorial. Immunologic injury partially attributable to the…
  • 2020 American Transplant Congress

    The Role of the Molecular Microscope to Guide Therapy for T-Cell Mediated Rejection in Kidney Transplants

    D. Kumar1, M. Demehin1, J. Christensen1, L. Kamal1, I. Moinuddin1, M. Levy1, C. Bhati1, A. King1, H. D. Massey1, P. Halloran2, G. Gupta1

    1Virginia Commonwealth University, Glen Allen, VA, 2ATAGC, Edmonton, AB, Canada

    *Purpose: Histologic lesions (I+T) to characterize T-cell mediated rejection (TCMR) can be non-specific. In some cases the inflammation may represent a ‘response to wounding’ rather…
  • 2020 American Transplant Congress

    Anti-HLA IgM Antibodies are Unaffected by Imlifidase (IdeS) Treatment

    A. Runström1, R. Bockermann1, K. Sjöholm1, K. M. Roupé1, Å. Schiött1, L. Winstedt1, C. Kjellman1, T. Lorant2

    1Hansa Biopharma AB, Lund, Sweden, 2Section of Transplantation Surgery, Department of Surgical Sciences, Uppsala, Sweden

    *Purpose: The immunoglobulin G (IgG)-degrading cysteine protease, imlifidase (IdeS) is an IgG endopeptidase under development as a rapid desensitization treatment in kidney transplantation. Imlifidase is…
  • 2020 American Transplant Congress

    Clinicopathological Evaluation of Long-Term Survivor More Than 10 Years after Living Kidney Transplant with Corticosteroid Early Withdrawal Protocol

    H. Sasaki1, T. Tanabe1, H. Higuchi1, T. Tsujimoto2, H. Harada1

    1Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan, 2Pharmacy, Sapporo City General Hospital, Sapporo, Japan

    *Purpose: We have previously reported that favorable short-term outcomes of kidney recipients were achieved by corticosteroid early withdrawal protocol (CSEW) compared to the conventional protocol…
  • 2020 American Transplant Congress

    Paired-Donor Kidney Exchange Has Comparable Early Graft Function to Directed Living Donor

    E. McCracken, A. Sites, B. Rawashdeh, A. Nishio-Lucar, A. Agarwal

    Transplant Surgery, University of Virginia, Charlottesville, VA

    *Purpose: Living kidney donation in the United States is associated with improved graft and patient survival. However, there is minimal data on graft function in…
  • 2020 American Transplant Congress

    Hepatitis C-Infected Donors and Hepatitis C-Infected Recipients: Analysis of Renal Transplant Outcomes

    H. Crossman1, M. Tavakol2, C. Freise2, P. Chin-Hong3

    1Internal Medicine Residency Program, UCSF, San Francisco, CA, 2Surgery, UCSF, San Francisco, CA, 3Infectious Disease, UCSF, San Francisco, CA

    *Purpose: Increased utilization of hepatitis C virus infected organs could reduce the supply demand mismatch in organ transplantation. At this time, there is little data…
  • 2020 American Transplant Congress

    Efficacy and Safety of Single-Dose Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction among Pediatric Kidney Transplant Recipients

    L. Porini Custodio, S. Stopa Martins, L. Almeida Viana, M. Pontello Cristelli, M. Rika Nakamura, H. Tedesco-Silva, J. Medina-Pestana

    Hospital do Rim, Sao Paulo, Brazil

    *Purpose: Induction therapy is a standard component of kidney transplant immunosuppression protocols. However, in the pediatric population, there are still uncertainties about the ideal induction…
  • 2020 American Transplant Congress

    Analyzing the Effect of a Closed Incision Negative Pressure Wound Therapy System on Wound Complications and Surgical Site Infections in Kidney Transplant Recipients: A Propensity Score Matched Analysis

    S. Lam, A. Huynh, J. M. Laurence

    Transplantation Services, Royal Prince Alfred Hospital, Sydney, Australia

    *Purpose: The purpose of this study is to determine if a closed incision negative pressure wound therapy (ciNPWT) system prevents wound complications and surgical site…
  • 2020 American Transplant Congress

    The Noninvasive Urinary Sediment Double Immunostaining Test Predicts BK Polyomavirus Nephropathy in Kidney Transplant Recipients

    G. Huang1, X. Chen1, S. Yang1, X. Hou2, H. Yang3, C. Wang1

    1The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2Guangzhou KingMed Center for Clinical Laboratory Co, Ltd, Guangzhou, China, 3Fuda Cancer Hospital, Jinan University, Fuda Cancer Hospital, Guangzhou, China

    *Purpose: This study aimed to improve the diagnostic value of decoy cells for BK polyomavirus associated-nephropathy (BKPyVAN) in kidney transplant recipients.*Methods: A total of 105…
  • 2020 American Transplant Congress

    Is the Epitope Mismatch Load Enough to Identify HLA-DQ Mismatches with a Low Risk for De Novo DSA Development?

    V. Jucaud1, M. Stegall2, C. Schinstock2, R. Heilman3, L. Rebellato4, M. Samaniego-Picota5, D. Leeser4, M. Gandhi2, J. Beaumont1, M. Everly1

    1Terasaki Research Institute, Los Angeles, CA, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Phoenix, AZ, 4East Carolina University, Greenville, NC, 5Henry Ford Transplant Institute, Detroit, MI

    *Purpose: The development of de novo donor-specific anti-HLA antibodies (dnDSA) remains a major risk factor for poor long-term kidney allograft outcomes. In particular, anti-HLA-DQ dnDSAs,…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences